tiprankstipranks
Consun Pharmaceutical Group Ltd. (HK:1681)
:1681
Hong Kong Market
Want to see HK:1681 full AI Analyst Report?

Consun Pharmaceutical Group Ltd. (1681) Income Statement

13 Followers

Consun Pharmaceutical Group Ltd. Income Statement

Last quarter (Q4 2025), Consun Pharmaceutical Group Ltd.'s total revenue was ¥1.85B, an increase of 25.73% from the same quarter last year. In Q4, Consun Pharmaceutical Group Ltd.'s net income was ¥579.77M. See Consun Pharmaceutical Group Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 3.42B¥ 2.97B¥ 2.59B¥ 2.34B¥ 2.04B
Gross Profit
¥ 2.67B¥ 2.24B¥ 1.92B¥ 1.76B¥ 1.53B
Operating Expenses
¥ 1.46B¥ 1.20B¥ 1.04B¥ 1.01B¥ 818.57M
Depreciation and Amortization
¥ 55.61M¥ 71.58M¥ 78.09M¥ 70.48M¥ 68.53M
EBITDA
¥ 1.21B¥ 1.05B¥ 963.06M¥ 785.89M¥ 728.71M
Operating Income
¥ 1.20B¥ 1.05B¥ 884.97M¥ 757.33M¥ 708.77M
Other Income/Expenses
¥ -5.96M¥ -24.95M¥ -21.26M¥ -10.93M¥ -12.90M
Pretax Income
¥ 1.20B¥ 1.02B¥ 863.70M¥ 746.39M¥ 695.86M
Net Income
¥ 1.08B¥ 910.46M¥ 784.53M¥ 682.91M¥ 590.17M
Per Share Metrics
Basic EPS
¥ 1.27¥ 1.11¥ 0.98¥ 0.86¥ 0.74
Diluted EPS
¥ 1.26¥ 1.09¥ 0.98¥ 0.86¥ 0.73
Weighted Average Shares Outstanding
855.61M 821.10M 800.54M 790.63M 801.58M
Weighted Average Shares Outstanding (Diluted)
855.13M 832.11M 799.17M 792.00M 804.70M
Currency in CNY

Consun Pharmaceutical Group Ltd. Earnings and Revenue History